New Date for the 4th Summit
The 4th Scientific Summit on Tobacco Harm Reduction: Novel Products, Research & Policy will be held virtually, on 29-30 September 2021, a week later from the initially announced dates. The 4th Scientific Summit […]
Read More →
A summary of selected sessions
The 3rd Scientific Summit on Tobacco Harm Reduction featured 50 renowned speakers from 26 countries. About 300 attendees from 38 countries* worldwide participated in the event. The key message of […]
Read More →
THR in low- and middle-income countries
The situation about tobacco harm reduction and how this approach is perceived in non-European countries, such as Indonesia, Costa Rica, Malaysia, Philippines, South Africa, Tunisia and India, was presented by […]
Read More →
Tobacco Harm Reduction as a Public Health Policy tool globally
The question whether Tobacco Harm Reduction should become a Public Health Policy tool globally, was discussed at a panel discussion, on Summit’s second day. Participants in this panel have prominent […]
Read More →
Declaration of Founding Members of SCOHRE
The founding of the International Association on Smoking Control & Harm Reduction (SCOHRE) was announced today, at the closing of the 3rd Scientific Summit. Forty scientists from 21 countries* voted, […]
Read More →
The doctor’s dilemma: alternative smoking products for adult smokers?
“The doctor’s dilemma: Providing guidance on alternative smoking products to adult smokers amid controversy and change” was the subject discussed in a panel discussion on the second day of the […]
Read More →
New Legislation on smoking control in Greece
The “New Legislation on smoking control in Greece” was the subject of Mr. Ioannis Faropoulos’ talk, as Scientific Advisor to the General Secretariat for Public Health of the Greek Ministry […]
Read More →
COVID-19 and Nicotinic Cholinergic System
The second day of the Summit started with the hot topic “COVID-19 and nicotinic cholinergic system: an interaction which affects Public Health”, discussed by Professors Konstantinos Poulas and Konstantinos Farsalinos. […]
Read More →
Clinical Assessment and Research
In the afternoon session entitled “Clinical Assessment and Research”, chaired by Dr Peter Harper and Dr Ignatios Ikonomidis, results from several studies on alternative tobacco products versus standard cigarette smoking […]
Read More →
The role of medical community in policy making on tobacco control
Professor David Khayat in his keynote lecture today, sought to answer the question “Could the scientific and medical community play a role in making policy makers to reconsider the tobacco […]
Read More →